MedTrace Logo

Efficacy of Diclofenac BCG Irrigations

NCT01542567 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-05-22

No results posted yet for this study

Summary

This study is designed to test the effectiveness of diclofenac suppositories in the prophylaxis of side effects caused by BCG bladder irrigations in bladder cancer patients.

Conditions

Interventions

DRUG

Abitren

SUPPOSITORIES 50 Mg 2 SUPPOSITORIES A WEEK

DRUG

Placebo

Placebo suppositories

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-05-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542567 on ClinicalTrials.gov